Building Brand Visibility in a Relationships-First Industry

How Rebound rebuilt the SEO foundation and AI-search readiness for a life sciences technology company to drive sustained inbound growth in a complex B2B market.

The Company + The Challenge

A global healthcare and pharma commercial consultancy with 400+ practitioners and 20+ years in market came to Rebound to build brand visibility and earn consideration from senior pharma leaders outside their existing network.

With 100+ brand launches across pharma and biotech, their reputation was strong, but built almost entirely through relationships. They needed to reach the senior commercial leaders who didn’t yet know their name.

Strong Reputation, Limited Digital Presence

20 years helping the world’s largest pharma companies build commercial momentum, yet their own brand had almost no digital presence where their best prospects worked.

LinkedIn Wasn’t Working

LinkedIn existed but wasn’t working: impressions without engagement, engagement without intent, no pipeline signal.

Expertise Trapped Inside Existing Relationships

The proof was there: deep therapeutic depth, 100+ launches, case studies competitors couldn’t match. But that story was trapped inside existing relationships.

Invisible to New Decision Makers

Outside their known network, they were invisible to exactly the commercial leaders they were best positioned to serve.

Why Rebound + Our Approach

Rebound was engaged as the client’s full LinkedIn partner across Paid and Organic.

The team led end-to-end: strategy, creative direction, execution, and performance reporting.

Paid: strategy, creative, campaign management, and reporting across four markets (US, UK, France, Switzerland).

Organic: strategic oversight to the client’s internal team, ensuring paid and organic worked as a single system, not parallel channels.

What We Actually Did

Results & Impact

The LinkedIn strategy transformed the client’s digital visibility among senior pharmaceutical decision-makers. Engagement rates significantly exceeded platform benchmarks while consistently reaching the exact audiences the firm wanted to influence.

Key outcomes included:

4.42% at launch → 5.82% in month two → 5.71% in month three, despite a 13% budget reduction.

10–13x above LinkedIn and internal benchmarks, improving as the algorithm learned.

Cost per engagement: 42–43% below benchmark.

Awareness Before Demand
H1 was a signal-building phase: LinkedIn Document Ads with an 80/20 budget split between always-on and conference amplification.
Every ad opened with a strategic question reflecting the audience’s real challenges, tested across multiple copy angles.

Paid LinkedIn works better for niche audiences precisely because the audience is small. When you know exactly who you’re reaching and build creative that speaks to their specific challenges, a modest budget generates disproportionate signal. Awareness built with discipline creates the warm, qualified audience that makes lead generation possible.

The retargeting pool built in H1 is exactly that asset. An approach built for senior buyers, relationship-conditioned markets, and firms whose reputation is already strong enough to convert interest, once it can be reached at scale.

Audience Targeting
Targeting: Director level and above, pharma and biotech, 201+ employees, across all four markets.

Paid and Organic as One System
Organic ran as a credibility layer: thought leadership, conference signal interpretation, and executive voice. Paid and organic as a flywheel: organic built credibility in the feed; paid amplified top assets beyond the existing follower base.

Campaign Execution
Month one focused on strategy and setup. Months two through four centered on the active campaign.

Quick Stats

Industry:

Healthcare & Pharma Commercial Consulting

Company Type:

Global Healthcare & Pharma Commercial Consultancy

Primary Channel:

LinkedIn (Paid & Organic)

Services:

Paid LinkedIn Strategy, Creative Direction, Campaign Management, Reporting, Organic
Strategy

Outcome:

10–13x engagement above LinkedIn and internal benchmarks; 5.82% peak CTR; 42–43% below CPE benchmark; built a warm, qualified retargeting audience.

Timeline:

Month one: strategy and setup. Months two through four: active campaign.

Rebound helped us think differently about paid search. Instead of chasing immediate conversions, we built a disciplined brand presence that showed up consistently where our buyers were researching. The structure, messaging, and reporting gave us confidence that SEM was supporting our long-term GTM goals.

— Marketing Leader, Global Life Sciences Technology Organization